Celltrion Finalizing Preparations for Third Plant's Commercial Production Celltrion announced on the 23rd that its third plant, located in Songdo, Incheon, is undergoing final validation before… Cheon Okhyeon 2024-07-23
Celltrion Receives UK Approval for Asthma Drug Biosimilar 'Xolair' Celltrion has announced that their biosimilar Omvoh (CT-P39), a treatment for allergic asthma and chronic idiopathic urticaria, has… Cheon Okhyeon 2024-07-09